Wells Fargo & Company Thermo Genesis Holdings, Inc. Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.18 - $11.25 $10 - $652	58 Added 84.06%	127 $0
Q2 2022 Aug 12, 2022	BUY	$0.28 - $0.67 $2 - $6	10 Added 16.95%	69 $0
Q1 2022 May 16, 2022	SELL	$0.54 - $1.11 $2 - $4	-4 Reduced 6.35%	59 $0
Q4 2021 Feb 14, 2022	BUY	$1.01 - $2.03 $4 - $8	4 Added 6.78%	63 $0
Q3 2021 Nov 15, 2021	SELL	$1.97 - $2.67 $13 - $18	-7 Reduced 10.61%	59 $0
Q2 2021 Aug 16, 2021	BUY	$2.15 - $2.99 $58 - $80	27 Added 69.23%	66 $0
Q1 2021 May 13, 2021	SELL	$2.19 - $3.98 $2 - $3	-1 Reduced 2.5%	39 $0
Q4 2020 Feb 09, 2021	SELL	$1.98 - $2.92 $479 - $706	-242 Reduced 85.82%	40 $0
Q3 2020 Nov 05, 2020	SELL	$2.9 - $6.4 $3,912 - $8,633	-1,349 Reduced 82.71%	282 $1,000
Q2 2020 Aug 13, 2020	BUY	$3.36 - $12.21 $5,376 - $19,536	1,600 Added 5161.29%	1,631 $9,000
Q1 2020 May 14, 2020	BUY	$1.72 - $5.8 $53 - $179	31 New	31 $0

Ticker THMO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,321,400
Description
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally cl...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.